RAAS Inhibitors and Risk of Covid-19

被引：19
|
作者：
Angeli, Fabio [1 ]
Verdecchia, Paolo [2 ]
Reboldi, Gianpaolo [3 ]
机构：
[1] Univ Insubria Maugeri, Tradate, Italy
[2] Hosp SM della Misericordia, Perugia, Italy
[3] Univ Perugia, Perugia, Italy
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 383卷 / 20期
关键词：
D O I：
10.1056/NEJMc2030446
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1990 / 1991
页数：3
相关论文
共 50 条
  • [21] Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors and Coronavirus Disease 2019 (COVID-19)
    Albashir, Ahmed Abdalazim Dafallah
    SOUTHERN MEDICAL JOURNAL, 2021, 114 (01) : 51 - 56
  • [22] Effect of RAAS Inhibitors in People with COVID-19: An Independent Participant Data Meta-Analysis
    Yi, Tae Won
    Mallitt, Kylie-Ann
    Wilcox, Arlen
    Puskarich, Michael A.
    Freilich, Daniel
    Geriak, Matthew
    Shikuma, Cecilia M.
    Jardine, Meg
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [23] RAAS-Blockade in COVID-19: The Ace of Spades?
    Agarwal, Krishna A.
    Kyriazis, Periklis P.
    Lecker, Stewart H.
    INDIAN JOURNAL OF NEPHROLOGY, 2021, 31 (04) : 423 - 424
  • [24] COVID-19 and the RAAS—a potential role for angiotensin II?
    Laurence W. Busse
    Jonathan H. Chow
    Michael T. McCurdy
    Ashish K. Khanna
    Critical Care, 24
  • [25] RAAS inhibition and beyond-cardiovascular medications in patients at risk of or affected by COVID-19
    Dutsch, Alexander
    Schunkert, Heribert
    HERZ, 2023, 48 (03) : 206 - 211
  • [26] Proton pump inhibitors increase risk of COVID-19
    Reactions Weekly, 2020, 1817 (1) : 12 - 12
  • [27] COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
    Sen, Selcuk
    Uresin, Ali Yagiz
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2020, 48 (07): : 631 - 634
  • [28] COVID-19 and the RAAS-a potential role for angiotensin II?
    Busse, Laurence W.
    Chow, Jonathan H.
    McCurdy, Michael T.
    Khanna, Ashish K.
    CRITICAL CARE, 2020, 24 (01)
  • [29] RAAS, ACE2 and COVID-19; a mechanistic review
    Elshafei, Ahmed
    Khidr, Emad Gamil
    El-Husseiny, Ahmed A.
    Gomaa, Maher H.
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (11) : 6465 - 6470
  • [30] Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin–angiotensin–aldosterone system (RAAS) inhibitors: a systematic review
    Chinonyerem O. Iheanacho
    Valentine U. Odili
    Uchenna I. H. Eze
    Future Journal of Pharmaceutical Sciences, 7
12345